The future of healing, distilled.
Purified apitoxin peptides. Dosed by AI. Engineered for absolute safety.
Quantified, not promised.
Every protocol run streams to our clinical registry. The numbers below are live aggregates — not marketing.
Eighteen peptides. Three do the work.
Melittin
Melittin integrates into lipid bilayers and induces transient toroidal pores, triggering controlled mechanotransduction. At sub-lytic concentrations it activates Phospholipase A2 cascades and drives fibroblast proliferation — the basis of the protocol's regenerative signal.
Real-time dosimetry.
Zero margin for harm.
BSerum's clinical stack monitors Phospholipase A₂ saturation, tryptase pre-elevation, and per-patient sensitivity drift across every session. Dose adjustments propagate in under 80ms — faster than a practitioner can lift the applicator.
A nightly ritual that rebuilds skin from the membrane up.
Two drops. Applied across cleansed skin. The melittin/PLA₂ complex initiates a controlled regenerative pulse — visible barrier recovery in 11 nights, validated against fractional CO₂ baselines.
Clinical efficacy.
Absolute safety.
Driven by AI.
A 30-day initiation is opening to 400 patients globally. Clinics applying for the B2B stack are reviewed within 14 days.